Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Serraflazyme Ingredients & Drug Interactions

by Cardiovascular Research

Tablet Or Pill Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Serraflazyme is a dietary supplement by Cardiovascular Research with 1 active ingredient. Its ingredients are commonly taken for inflammation and swelling, sinus and respiratory congestion, pain after surgery or injury.Based on those ingredients, 122 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Serrapeptase. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Serraflazyme by Cardiovascular Research

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

Serraflazyme contains one active ingredient: serrapeptase, an enzyme extracted from silkworm gut bacteria. The product also includes several inactive ingredients—microcrystalline cellulose, dicalcium phosphate, hydroxypropyl methylcellulose, silicon dioxide, magnesium stearate, and food glaze—which serve as binders, fillers, and coating.

Does it work?

Couldn't assess
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not assessable

This is a single-ingredient Serrapeptase product and its label doesn't state a use — see Serrapeptase's own graded uses on its monograph.

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.

The evidence for serrapeptase is currently insufficient to rate it reliably for any of its common uses. Manufacturers market it for chronic bronchitis, asthma, atherosclerosis, back pain, and osteoporosis, but we don't yet have strong clinical data backing those claims.

That doesn't mean it doesn't work—it means more research is needed before we can say.

The evidence, ingredient by ingredient Serrapeptase

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Serrapeptase appears to be generally well tolerated in the short term, with most people experiencing no trouble. When side effects do occur, they're usually mild—some people report stomach pain, general gastrointestinal upset, or nausea, though these happen at about the same rate as placebo in trials.

A rare serious side effect (bullous pemphigoid, a blistering skin condition) has been reported. Long-term safety hasn't been well studied, so caution is warranted with extended use.

The safety data is insufficient during pregnancy, so it's best avoided then. There's no reliable safety information for breastfeeding either, so skip it if you're nursing.

Side effects, ingredient by ingredient Serrapeptase

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Serrapeptase.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs.
  • For scale: 122 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking Serraflazyme, double-check with your doctor or pharmacist if you're on any blood thinners (anticoagulants) or antiplatelet drugs like aspirin or clopidogrel—serrapeptase may increase bleeding risk with these medications.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Serraflazyme may appeal to people looking for an enzyme supplement, though the clinical evidence doesn't yet support its common uses. If you take blood thinners or antiplatelet drugs, you'll need to clear this with your doctor or pharmacist first because of the theoretical bleeding risk.

Talk it over with your own healthcare provider before starting, especially if you're pregnant, breastfeeding, or taking any prescription medications.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Mar 22, 2023.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Serraflazyme, straight from the product label.

Brand Cardiovascular Research
Barcode (UPC) 696859034909
Net contents 100 Tablet(s)
Market status On market
Date entered into DSLD Mar 22, 2023
DSLD ID 283446
Product type Non-nutrient/non-botanical
Supplement form Tablet Or Pill
Dietary claims / uses All Other
Intended target group(s) Adult (18 - 50 Years), No Allergies, Dairy Free, Sugar Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Serraflazyme by Cardiovascular Research, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container
100
UPC/BARCODE
696859034909
IngredientAmount% DV
Serrapeptase5 mg--

Other ingredients: Microcrystalline Cellulose, Dicalcium Phosphate, Hydroxypropyl Methylcellulose, Silicon Dioxide, Magnesium Stearate, Food Glaze

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
FDA Statement of Identity

Dietary Supplement

Formula

Serraflazyme contains 5 mg of the purified enzyme, Serratio Peptidase, in an enterically-coated tablet.

Serrapeptase Enzyme (Serratio Peptidase)

Formulation

This preparation is scientifically designed for maximal absorption.

Free of yeast, corn, wheat, sugar, starch, phenols, egg, milk, and other common food and chemical allergens.

Suggested/Recommended/Usage/Directions

Directions Take one tablet daily, preferably before meals, or as directed by a physician.

General Statements

Ecological Formulas

See for yourself

Serraflazyme by Cardiovascular Research label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Serraflazyme by Cardiovascular Research

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Tablet(s) Dosage formTablet Or Pill Servings per container100 Amounts shown are per serving.

Serrapeptase

Interacts with
122 drugs
5 mg per serving Form: Serratiopeptidase

Serrapeptase is an enzyme marketed to reduce inflammation, swelling, pain, and mucus, but the human evidence is limited and mostly low quality. If you...

Serrapeptase monograph & interactions

Other (inactive) ingredients: Microcrystalline Cellulose, Dicalcium Phosphate, Hydroxypropyl Methylcellulose, Silicon Dioxide, Magnesium Stearate, Food Glaze. These complete the product’s ingredient list but are not active constituents.

Interaction report

Serraflazyme by Cardiovascular Research Drug Interactions

Want to check YOUR meds against Serraflazyme?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
122Drugs
122 Moderate

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in Serraflazyme with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Serrapeptase1 drug type · 122 drugs

Anticoagulant/Antiplatelet Drugs

Theoretically, taking serrapeptase with drugs that have antiplatelet or anticoagulant effects might increase the risk of bruising and bleeding.
In vitro research shows that serrapeptase has fibrinolytic activity.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for Serraflazyme, from the product label.

Cardiovascular Research

See all Cardiovascular Research products
Name
Cardiovascular Research, LTD.
Street Address
1061-B Shary Circle
City
Concord
State
CA
ZipCode
94518
Pharmacist Counseling Corner

Serraflazyme by Cardiovascular Research: Common Questions

Does Serraflazyme by Cardiovascular Research interact with any medications?
Yes. Based on its ingredients, Serraflazyme has a known interaction with 122 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Serraflazyme contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is serrapeptase safe to take long-term?
Not much is known about long-term safety. Serrapeptase appears well tolerated in the short term, but we don't have reliable data on what happens with extended use, so caution is advised if you're thinking of taking it regularly. Talk with your doctor about your individual situation.
What are the common side effects?
Most people tolerate it well. When side effects do happen, they're typically mild—stomach pain, general digestive upset, or nausea—and they occur about as often as placebo in trials. A rare serious side effect (a blistering skin condition) has been reported but is uncommon.
Can I take this while pregnant or breastfeeding?
No—there isn't enough safety data for pregnancy, so it's best avoided. If you're breastfeeding, there's no reliable safety information, so skip it. Talk with your doctor or pharmacist for personalized advice if you're in either situation.
Does serrapeptase actually work for the conditions it's marketed for?
The evidence is currently insufficient to rate it reliably. Serrapeptase is marketed for chronic bronchitis, asthma, atherosclerosis, back pain, and osteoporosis, but we don't yet have strong clinical data supporting those uses. That means more research is needed.
What is serrapeptase and where does it come from?
Serrapeptase is an enzyme isolated from the gut bacteria of silkworms. In laboratory studies, it shows fibrinolytic activity, meaning it can break down blood clots—which is why it's marketed for cardiovascular and inflammation-related conditions.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Serraflazyme is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Serraflazyme label
Sources

Sources & How We Checked

Serraflazyme's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 2 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Serrapeptase 2 references
  1. Tachibana M, Mizukoshi O, Harada Y, et al. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica 1984;3:526-30..
  2. Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990;18:379-88.. PubMed

See these in context on the Serrapeptase monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring